These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17107395)

  • 1. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists.
    Ashcroft DM; Seston E; Griffiths CE
    Br J Dermatol; 2006 Dec; 155(6):1236-41. PubMed ID: 17107395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.
    Seston EM; Ashcroft DM; Griffiths CE
    Arch Dermatol; 2007 Sep; 143(9):1175-9. PubMed ID: 17875880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
    Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
    Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
    Neri L; Miracapillo A
    G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders.
    Roelofzen JH; Aben KK; Khawar AJ; Van de Kerkhof PC; Kiemeney LA; Van Der Valk PG
    Eur J Dermatol; 2007; 17(5):416-21. PubMed ID: 17673386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals.
    De Jager ME; Van de Kerkhof PC; De Jong EM; Seyger MM
    J Dermatolog Treat; 2009; 20(5):254-8. PubMed ID: 19418330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
    Feldman SR; Regnier SA; Chirilov A; Hey F; Gilloteau I; Cella D
    J Am Acad Dermatol; 2019 Jun; 80(6):1650-1657. PubMed ID: 30703461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare).
    Schaarschmidt ML; Herr R; Gutknecht M; Wroblewska K; Gerdes S; Sticherling M; Augustin M; Peitsch WK
    Acta Derm Venereol; 2018 Feb; 98(2):200-205. PubMed ID: 29110022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives.
    Burden AD; Warren RB; Kleyn CE; McElhone K; Smith CH; Reynolds NJ; Ormerod AD; Griffiths CE;
    Br J Dermatol; 2012 Mar; 166(3):545-54. PubMed ID: 22356636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatologists' knowledge of and preferences regarding topical steroids.
    Sandoval LF; Davis SA; Feldman SR
    J Drugs Dermatol; 2013 Jul; 12(7):786-9. PubMed ID: 23884491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert report on psoriasis: Spanish dermatologists' opinions on the use of biologic agents to manage moderate to severe psoriasis in adults.
    Puig L; de la Cueva P; Linares M; Suarez J; Velasco M; Vidal D; Zulaica A; García-Calvo C
    Actas Dermosifiliogr; 2013 Jun; 104(5):400-8. PubMed ID: 23669590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Current State of Dermatologists' Familiarity and Perspectives of Biosimilars for the Treatment of Psoriasis: A Global Cross-Sectional Survey.
    Manalo IF; Gilbert KE; Wu JJ
    J Drugs Dermatol; 2017 Apr; 16(4):336-343. PubMed ID: 28403267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tradeoffs and decision-making in moderate to severe psoriasis for oral versus injectable treatments: data from patients and dermatologists in Australia.
    Smith SD; Fifer S; Edwards M; Walter A; Zhong Y; Zhuo J; West B; Spelman L
    J Dermatolog Treat; 2024 Dec; 35(1):2339440. PubMed ID: 39079697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.
    Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M
    Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.
    Smith CH; Anstey AV; Barker JN; Burden AD; Chalmers RJ; Chandler DA; Finlay AY; Griffiths CE; Jackson K; McHugh NJ; McKenna KE; Reynolds NJ; Ormerod AD;
    Br J Dermatol; 2009 Nov; 161(5):987-1019. PubMed ID: 19857207
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of childhood psoriasis in France. A national survey among general practitioners, pediatricians, and dermatologists.
    Mahé E; Bursztejn AC; Phan A; Corgibet F; Beauchet A
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists.
    Wakkee M; Lugtenberg M; Spuls PI; de Jong EM; Thio HB; Westert GP; Nijsten T
    Br J Dermatol; 2008 Aug; 159(2):426-32. PubMed ID: 18616791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.
    Berends MA; de Jong EM; van de Kerkhof PC; Gerritsen MJ
    Dermatology; 2007; 215(1):45-52. PubMed ID: 17587839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis.
    de la Cueva Dobao P; Notario J; Ferrándiz C; López Estebaranz JL; Alarcón I; Sulleiro S; Borrás J; Daudén E; Carrascosa JM; Sánchez Carazo JL; Monte Boquet E; Puig L
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1214-1223. PubMed ID: 31037770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists.
    Taylor K; Swan DJ; Affleck A; Flohr C; Reynolds NJ;
    Br J Dermatol; 2017 Jun; 176(6):1617-1623. PubMed ID: 27943248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.